( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
Audited
UnAudited
Audited
Audited
Net Sales
3931.83
3061.96
2072.37
3084.83
Total Expenditure
2425.28
2108.73
1563.29
2235.26
PBIDT (Excl OI)
1506.55
953.23
509.08
849.57
Other Income
46.99
98.37
159.38
57.79
Operating Profit
1553.54
1051.6
668.46
907.36
Exceptional Items
NA
NA
NA
NA
PBDT
1544.93
1045.81
662.07
901.33
Depreciation
98.25
84.02
81.31
72.98
Profit Before Tax
1446.68
961.79
580.76
828.35
Tax
384.49
243.24
140.65
201.18
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
1062.19
718.55
440.11
627.17
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
1062.19
718.55
440.11
627.17
Minority Interest
17.41
3.85
2.83
-2.33
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
1079.6
722.41
442.93
624.83
Equity Capital
409.36
409.36
409.34
409.34
Calculated EPS
13.18
8.82
5.41
7.63
Calculated EPS (Annualised)
52.74
35.29
21.64
30.52
No of Public Share Holdings
55129706
55127506
55127506
26214832
% of Public Share Holdings
67.34
67.34
67.34
64.04
PBIDTM% (Excl OI)
38.31
31.13
24.56
27.54
PBIDTM%
39.51
34.34
32.25
29.41
PBDTM%
39.29
34.15
31.94
29.21
PBTM%
36.79
31.41
28.02
26.85
PATM%
27.01
23.46
21.23
20.33